Pharmaceuticals (490) | Stock Agreements (490)
Browse by Company
-
Acasti Pharma Inc. (2)
-
ACELRX PHARMACEUTICALS INC (2)
-
Acer Therapeutics Inc. (1)
-
Acreage Holdings, Inc. (6)
-
ACURA PHARMACEUTICALS, INC (1)
-
Adamis Pharmaceuticals Corp (4)
-
ADIAL PHARMACEUTICALS, INC. (3)
-
AERIE PHARMACEUTICALS INC (4)
-
Aerpio Pharmaceuticals, Inc. (3)
-
AGILE THERAPEUTICS INC (6)
-
Akers Biosciences, Inc. (2)
-
Akorn (1)
-
Amag Pharmaceuticals (2)
-
Ampio Pharmaceuticals, Inc. (4)
-
Amylyx Pharmaceuticals, Inc. (2)
-
AN2 Therapeutics, Inc. (2)
-
Anebulo Pharmaceuticals, Inc. (2)
-
Angion Biomedica Corp. (3)
-
ANI Pharma Inc (3)
-
Applied BioSciences Corp. (2)
-
APRICUS BIOSCIENCES, INC. (2)
-
Aquestive Therapeutics, Inc. (2)
-
Artemis Therapeutics, Inc. (1)
-
ARVINAS, INC. (2)
-
ATAI Life Sciences B.V. (8)
-
Atea Pharmaceuticals, Inc. (3)
-
Athira Pharma, Inc. (3)
-
AXIM BIOTECHNOLOGIES, INC. (2)
-
AYTU BIOSCIENCE, INC (2)
-
Baudax Bio, Inc. (3)
-
Bespoke Extracts, Inc. (2)
-
Biofrontera Inc. (2)
-
BioPharmX Corp (5)
-
Blue Water Acquisition Corp. (5)
-
Boston Therapeutics, Inc. (1)
-
Bristol-Myers Squibb (1)
-
Canbiola, Inc. (5)
-
CANNAPHARMARX, INC. (1)
-
Canopy Growth Corp (6)
-
Cara Therapeutics, Inc. (2)
-
CARDAX, INC. (1)
-
CASSAVA SCIENCES INC (1)
-
Catalent Inc (5)
-
Cerecor Inc. (2)
-
Charlotte's Web Holdings, Inc. (1)
-
CHIASMA, INC (1)
-
CinCor Pharma, Inc. (3)
-
Cingulate Inc. (5)
-
Citius Pharmaceuticals, Inc. (2)
-
Clearside Biomedical, Inc. (1)
-
Clever Leaves Holdings Inc. (3)
-
Cocrystal Pharma, Inc. (1)
-
COGNITION THERAPEUTICS INC (5)
-
Columbia Care Inc. (3)
-
Context Therapeutics Inc. (1)
-
Corcept Therapeutics Incorporated (2)
-
CorMedix Inc. (1)
-
Cronos Group Inc. (6)
-
CUMBERLAND PHARMACEUTICALS INC (2)
-
Cure Pharmaceutical Holding Corp. (2)
-
CymaBay Therapeutics, Inc. (3)
-
Cyteir Therapeutics, Inc. (2)
-
Dermata Therapeutics, Inc. (2)
-
DiCE MOLECULES HOLDINGS, LLC (2)
-
DURECT CORP (4)
-
Edgewise Therapeutics, Inc. (2)
-
Elanco Animal Health Inc (10)
-
Evofem Biosciences, Inc. (2)
-
Exactus, Inc. (5)
-
EYEGATE PHARMACEUTICALS INC (1)
-
EyePoint Pharmaceuticals, Inc. (2)
-
Fulcrum Therapeutics, Inc. (3)
-
GRAYBUG VISION, INC. (4)
-
GridIron BioNutrients, Inc. (2)
-
Harmony Biosciences Holdings, Inc. (2)
-
Haymaker Acquisition Corp. III (4)
-
Horizon Pharma plc (2)
-
Hoth Therapeutics, Inc. (1)
-
Ikena Oncology, Inc. (2)
-
IMARA Inc. (3)
-
INNOVATE BIOPHARMACEUTICALS, INC. (1)
-
IntelGenx Technologies Corp. (1)
-
Intersect ENT, Inc. (1)
-
Intra-Cellular Therapies, Inc. (2)
-
Jaguar Health, Inc. (7)
-
Jazz Pharmaceuticals plc (6)
-
Johnson & Johnson (1)
-
Journey Medical Corp (4)
-
Jushi Holdings Inc. (7)
-
Kala Pharmaceuticals, Inc. (2)
-
Kaleido Biosciences, Inc. (2)
-
Kannalife Inc (1)
-
KEMPHARM, INC (2)
-
Landos Biopharma, Inc. (2)
-
Lannett Company, Inc. (1)
-
Lilly (Eli) & Co. (19)
-
Liquidia Corp (5)
-
Liquidia Technologies Inc (2)
-
Longboard Pharmaceuticals, Inc. (3)
-
Lyra Therapeutics, Inc. (4)
-
Marijuana Co of America, Inc. (2)
-
MARINUS PHARMACEUTICALS INC (1)
-
Medicine Man Technologies, Inc. (6)
-
Menlo Therapeutics Inc. (1)
-
Merck (1)
-
MICROCHANNEL TECHNOLOGIES CORP (7)
-
Milestone Pharmaceuticals Inc. (3)
-
Mind Medicine (MindMed) Inc. (2)
-
MJ Holdings, Inc. (4)
-
MYnd Analytics, Inc. (4)
-
MyoKardia Inc (2)
-
NEKTAR THERAPEUTICS (1)
-
Neos Therapeutics, Inc. (1)
-
Neuralstem, Inc. (7)
-
NGM BIOPHARMACEUTICALS INC (4)
-
NovaBay Pharmaceuticals, Inc. (2)
-
Novan, Inc. (4)
-
OCULAR THERAPEUTIX, INC (1)
-
OMEROS CORP (2)
-
Onconova Therapeutics, Inc. (4)
-
OptiNose, Inc. (1)
-
ORAMED PHARMACEUTICALS INC. (1)
-
Organon & Co. (1)
-
Pacira Pharmaceuticals, Inc. (3)
-
Panacea Acquisition Corp (6)
-
Perrigo (2)
-
Petros Pharmaceuticals, Inc. (3)
-
Pfizer (2)
-
Phathom Pharmaceuticals, Inc. (3)
-
PLIANT THERAPEUTICS, INC. (2)
-
PLx Pharma Inc. (1)
-
Processa Pharmaceuticals, Inc. (1)
-
ProPhase Labs, Inc. (3)
-
PROTEO INC (3)
-
Provention Bio, Inc. (1)
-
QUANTA INC (2)
-
Rain Therapeutics Inc. (3)
-
Rani Therapeutics Holdings, Inc. (3)
-
REATA PHARMACEUTICALS INC (9)
-
Recro Pharma, Inc. (8)
-
RespireRx Pharmaceuticals Inc. (9)
-
resTORbio, Inc. (5)
-
Revance Therapeutics, Inc. (1)
-
Satsuma Pharmaceuticals, Inc. (6)
-
Scopus BioPharma Inc. (1)
-
SCYNEXIS INC (9)
-
SenesTech, Inc. (1)
-
Strongbridge Biopharma plc (1)
-
Target Group Inc. (1)
-
Tarsus Pharmaceuticals, Inc. (3)
-
TAURIGA SCIENCES, INC. (2)
-
Tenzing Acquisition Corp. (1)
-
Terns Pharmaceuticals, Inc. (2)
-
Terra Tech Corp. (10)
-
TETRAPHASE PHARMACEUTICALS INC (1)
-
TFF Pharmaceuticals, Inc. (2)
-
TherapeuticsMD, Inc. (1)
-
Theseus Pharmaceuticals, Inc. (3)
-
TITAN PHARMACEUTICALS INC (1)
-
Trevi Therapeutics, Inc. (2)
-
Tricida, Inc. (3)
-
Trulieve Cannabis Corp. (1)
-
Urovant Sciences Ltd. (1)
-
Vallon Pharmaceuticals, Inc. (3)
-
Ventyx Biosciences, Inc. (3)
-
Verrica Pharmaceuticals Inc. (1)
-
Virpax Pharmaceuticals, Inc. (4)
-
VIVUS INC (1)
-
Zoetis (1)
-
Zomedica Pharmaceuticals Corp. (1)
Recent Contracts
-
Form of Stock Award Agreement, dated June 14, 2022, between Director and Medicine Man Technologies, Inc
(Medicine Man Technologies, Inc., Filed With SEC on August 11, 2022)
-
Stock Award Agreement, dated June 24, 2022, between Jonathan Berger and Medicine Man Technologies, Inc
(Medicine Man Technologies, Inc., Filed With SEC on August 11, 2022)
-
Form of Series B Preferred Stock Certificate of Registrant
(Neuralstem, Inc., Filed With SEC on August 9, 2022)
-
Virpax Pharmaceuticals, Inc. Form of Nonqualified Stock Option Grant Agreement
(Virpax Pharmaceuticals, Inc., Filed With SEC on July 25, 2022)
-
Virpax Pharmaceuticals, Inc. Form of Restricted Stock Award Agreement
(Virpax Pharmaceuticals, Inc., Filed With SEC on July 25, 2022)
-
Virpax Pharmaceuticals, Inc. Form of Restricted Stock Unit Award Agreement
(Virpax Pharmaceuticals, Inc., Filed With SEC on July 25, 2022)
-
Form of Journey Medical Corporation 2015 Stock Plan Restricted Stock Unit Award Agreement
(Journey Medical Corp, Filed With SEC on July 22, 2022)
-
Subordinate Voting Shares Specimen Stock Certificate
(Jushi Holdings Inc., Filed With SEC on July 22, 2022)
-
Form of Stock Option Grant and Agreement for Directors
(Jushi Holdings Inc., Filed With SEC on July 22, 2022)
-
Form of Stock Option Grant and Agreement for Employees and Certain Named Executive Officers
(Jushi Holdings Inc., Filed With SEC on July 22, 2022)